JUBPSG 6.000% 05Mar2024 Corp (USD)

Bond Factsheet

Matured/ Called

Jubilant Pharma Ltd/SG

Indicative

Full Lot

Bid Price

102.250

Change in Bid Price

Bid Yield (%)

3.395 %

Change in Bid Yield

remove 0.008

Ask Price

103.000

Change in Ask Price

Ask Yield (%)

2.558 %

Change in Ask Yield

remove 0.011

Indicative price as of 10 Apr 2023, 12:00am

chevron_leftchevron_right

Bond Information

Jubilant Pharma Limited of Singapore manufactures generic pharmaceutical products. The Company provides radio pharmaceuticals and allergy therapy products. Jubilant Pharma serves customers in the United States and Singapore.

Bond Issuer

Jubilant Pharma Ltd/SG

Guarantor

Announcement Date

28 Feb 2019

Issue Date

05 Mar 2019

Maturity Date

05 Mar 2024

Years to Maturity / Next Call

- / -

Modified Duration

Issue / Reoffer Price

100.000

Issue / Reoffer Yield

6.000

Coupon Type

Fixed

Annual Coupon Rate

6.000

Coupon Frequency

Semi Annually

Seniority

Senior Unsecured

Reference Rate

ISIN

XS1958658509

CUSIP

AX4504244

Bond Currency

USD

Total Issue Size

200,000,000

Min. Investment Quantity (Nominal)

USD 200,000

Incremental Quantity (Nominal)

USD 1,000

Bond Type

High Yield Corporate

Bond Sector

Health Care

Bond Sub Sector

Pharmaceuticals

Issuer Credit Rating (S&P/ Fitch)

***/ W.R

Bond Credit Rating (S&P/ Fitch)

***/ W.R

Shariah Compliant

Exchange Listed

SGX

Bond Feature(s)

Issuer Call

At any time on or after March 5, 2022 and prior to maturity, upon not less than 30 nor more than 60 days' notice to the Holders and the Trustee, the Company may redeem all or part of the Notes at the following redemption prices (expressed as percentages of their principal amount at maturity), plus accrued and unpaid interest and Additional Amounts, if any, to the redemption date, if redeemed during the 12-month period commencing on March 5 of the years set forth below:

Year	Redemption Price
05 March 2022	103.000%
05 March 2023	101.500%
2024 and thereafter	100%

Make Whole Call

At any time prior to March 5, 2022, upon not less than 30 nor more than 60 days' notice to the Holders and the Trustee, the Company may on any one or more occasions redeem all or part of the Notes at a redemption price equal to 100% of the principal amount thereof plus the Applicable Redemption Premium as of, and accrued and unpaid interest and Additional Amounts, if any, to, the redemption date, subject to the rights of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date. Neither the Trustee nor the Paying Agent shall be responsible for calculating or verifying the Applicable Redemption Amount.

"Applicable Redemption Premium" means, with respect to any Note on any redemption date, the greater of:

(1) 1.0% of the principal amount of such Note; and

(2) the excess of:

(a) the present value at such redemption date of: (x) the principal amount of such Notes; plus (y) all required interest payments that would otherwise be due to be paid on such Note during the period between the redemption date and March 5, 2022 (excluding accrued but unpaid interest), computed using a discount rate equal to the U.S. Treasury Rate at such redemption date plus 50 basis points; over

(b) the outstanding principal amount of such Note.

Change Control Put

Not later than 30 days following a Change of Control, unless the Company has previously or concurrently sent a redemption notice with respect to all, but not part, of the outstanding Notes as described under "Optional Redemption," the Company will make an Offer to Purchase all outstanding Notes (a "Change of Control Offer") at a purchase price equal to 101% of the principal amount thereof plus accrued and unpaid interest, if any, to the Offer to Purchase Payment Date (as defined in clause (2) of the definition of "Offer to Purchase").

"Change of Control" means the occurrence of one or more of the following events:

(1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of the Company and the Restricted Subsidiaries, taken as a whole, to any "person" within the meaning of Section 13(d) of the Exchange Act, other than to one or more Permitted Holders;

(2) the Company consolidates with, or merges with or into, any Person (other than one or more Permitted Holders), or any Person consolidates with, or merges with or into, the Company, other than any such transaction where holders of a majority of the Voting Stock of the Company, immediately prior to such transaction, hold securities of the surviving or transferee Person, immediately after such transaction, that represent at least a majority of the Voting Stock of such surviving or transferee Person and in substantially the same proportion as before such transaction;

(3) (a) the Permitted Holders are collectively the beneficial owners (as such term is used in Rule 13d-3 of the Exchange Act) of less than 26% of the total voting power of the Voting Stock of the Company; and (b) the Permitted Holders cease to possess, directly or indirectly, the power to direct or cause the direction of the management, the Board of Directors and/or the policies of the Company, whether through the ownership of Voting Stock, by contract or otherwise;

(4) any "person" or "group" (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) other than the Permitted Holders is or becomes the "beneficial owner" (as such term is used in Rule 13d-3 of the Exchange Act), directly or indirectly, of more of the total voting power of the Voting Stock of the Company than is beneficially owned by the Permitted Holders; or

(5) the adoption of a plan relating to the liquidation or dissolution of the Company.

Equity Call

At any time prior to March 5, 2022, upon not less than 30 days nor more than 60 days' notice to the Holders and the Trustee, the Company may also redeem up to 35% of the aggregate principal amount of Notes at a redemption price of 106.00% of their principal amount, plus accrued and unpaid interest and Additional Amounts, if any, to the redemption date, with the proceeds from one or more Equity Offerings of the Company.

The Company may only do this, however, if:

(a) at least 65% of the aggregate principal amount of Notes that were initially issued would remain outstanding immediately after the proposed redemption; and

(b) the redemption occurs within 120 days after the closing of such Equity Offering.

Bondsupermart strives to ensure the accuracy and relevance of the information provided here. If the information is not up-to-date or erroneous, we appreciate feedback to keep it accurate.